Recombinant human interleukin-7 ( CYT 107 ) promotes T-cell recovery after allogeneic stem cell transplantation

1Adult Bone Marrow Transplantation Service, and 2Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; 3Weill Cornell Medical College; New York, NY; 4Ludwig Center for Cancer Immunotherapy, and 5Melanoma and Sarcoma Service, Memorial Sloan-Kettering Cancer Center, New York, NY; 6Cytheris, Issy Les Moulineaux, France; and 7Department of Biostatistics and Epidemiology, Memorial Sloan-Kettering Cancer Center, New York, NY

[1]  J. Blay,et al.  Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients , 2012, Oncoimmunology.

[2]  M. Lederman,et al.  Effects of Recombinant Human Interleukin 7 on T-Cell Recovery and Thymic Output in HIV-Infected Patients Receiving Antiretroviral Therapy: Results of a Phase I/IIa Randomized, Placebo-Controlled, Multicenter Study , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  F. Miedema,et al.  Maintenance of peripheral naive T cells is sustained by thymus output in mice but not humans. , 2012, Immunity.

[4]  J. Patel,et al.  A case of progressive multifocal leukoencephalopathy and idiopathic CD4+ lymphocytopenia. , 2010, The Journal of antimicrobial chemotherapy.

[5]  J. Wolchok,et al.  Preoperative CTLA-4 Blockade: Tolerability and Immune Monitoring in the Setting of a Presurgical Clinical Trial , 2010, Clinical Cancer Research.

[6]  S. Steinberg,et al.  Phase I Study of Recombinant Human Interleukin-7 Administration in Subjects with Refractory Malignancy , 2010, Clinical Cancer Research.

[7]  J. Goldberg,et al.  Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT , 2010, Bone Marrow Transplantation.

[8]  P. Ljungman,et al.  Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignancies. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[9]  D. Klatzmann,et al.  High diversity of the immune repertoire in humanized NOD.SCID.γc−/− mice , 2009, European journal of immunology.

[10]  M. Lederman,et al.  IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. , 2009, Blood.

[11]  C. Rouzioux,et al.  Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. , 2009, The Journal of clinical investigation.

[12]  D. Venzon,et al.  Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets , 2008, The Journal of experimental medicine.

[13]  S. Jhanwar,et al.  Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[14]  S. Rosenberg,et al.  IL-7 Administration to Humans Leads to Expansion of CD8+ and CD4+ Cells but a Relative Decrease of CD4+ T-Regulatory Cells , 2006, Journal of immunotherapy.

[15]  J. Altman,et al.  Loss of CD127 Expression Defines an Expansion of Effector CD8+ T Cells in HIV-Infected Individuals1 , 2005, The Journal of Immunology.

[16]  Roxanne Y. Williams,et al.  Generation of CMV-specific T lymphocytes using protein-spanning pools of pp65-derived overlapping pentadecapeptides for adoptive immunotherapy. , 2004, Blood.

[17]  B. Logan,et al.  Host Conditioning Is a Primary Determinant in Modulating the Effect of IL-7 on Murine Graft-versus-Host Disease1 , 2004, The Journal of Immunology.

[18]  S. Swain,et al.  IL-7 Promotes the Transition of CD4 Effectors to Persistent Memory Cells , 2003, The Journal of experimental medicine.

[19]  E. Wherry,et al.  Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells , 2003, Nature Immunology.

[20]  M. V. D. van den Brink,et al.  IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation. , 2003, The Journal of clinical investigation.

[21]  T. Fry,et al.  Interleukin 7 worsens graft-versus-host disease. , 2002, Blood.

[22]  Andreas Radbruch,et al.  Two Subsets of Naive T Helper Cells with Distinct T Cell Receptor Excision Circle Content in Human Adult Peripheral Blood , 2002, The Journal of experimental medicine.

[23]  E. Pamer,et al.  Quantitation, selection, and functional characterization of Epstein-Barr virus-specific and alloreactive T cells detected by intracellular interferon-gamma production and growth of cytotoxic precursors. , 2002, Blood.

[24]  M. Perales,et al.  Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease. , 2001, Blood.

[25]  T. Fry,et al.  IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation. , 2001, Blood.

[26]  A. Nademanee,et al.  Solid cancers after bone marrow transplantation. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  Eric J. Kunkel,et al.  CCR7 Expression and Memory T Cell Diversity in Humans1 , 2001, The Journal of Immunology.

[28]  S. Jameson,et al.  Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo , 2000, Nature Immunology.

[29]  R. Collins,et al.  Assessment of thymic output in adults after haematopoietic stemcell transplantation and prediction of T-cell reconstitution , 2000, The Lancet.

[30]  S. Jameson,et al.  Expression of the transcription factor lung Krüppel-like factor is regulated by cytokines and correlates with survival of memory T cells in vitro and in vivo. , 1999, Journal of immunology.

[31]  R. V. van Lier,et al.  Faces and phases of human CD8 T-cell development. , 1999, Immunology today.

[32]  Andreas Hutloff,et al.  ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28 , 1999, Nature.

[33]  S. Mackinnon,et al.  Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. , 1999, Blood.

[34]  S. Singhal,et al.  Identification of patients who may benefit from prophylactic immunotherapy after bone marrow transplantation for acute myeloid leukemia on the basis of lymphocyte recovery early after transplantation. , 1998, Blood.

[35]  Alan S. Perelson,et al.  Turnover of CD4+ and CD8+ T Lymphocytes in HIV-1 Infection as Measured by Ki-67 Antigen , 1998, The Journal of experimental medicine.

[36]  C. Feighery,et al.  Human small intestinal epithelial cells secrete interleukin-7 and differentially express two different interleukin-7 mRNA Transcripts: implications for extrathymic T-cell differentiation. , 1997, Human immunology.

[37]  M. Rep,et al.  Phenotypic and Functional Separation of Memory and Effector Human CD8+ T Cells , 1997, The Journal of experimental medicine.

[38]  N. Solvason,et al.  The earliest T lineage-committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression. , 1997, Immunity.

[39]  I. Weissman,et al.  Bcl-2 Rescues T Lymphopoiesis in Interleukin-7 Receptor–Deficient Mice , 1997, Cell.

[40]  T. Polyak,et al.  Immune reconstitution following T-cell depleted bone marrow transplantation: effect of age and posttransplant graft rejection prophylaxis. , 1997, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[41]  K. Sullivan,et al.  Infectious morbidity in long‐term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts , 1997, American journal of hematology.

[42]  D. Hamann,et al.  Heterogeneity of the human CD4+ T-cell population: two distinct CD4+ T-cell subsets characterized by coexpression of CD45RA and CD45RO isoforms. , 1996, Blood.

[43]  G. Friedman,et al.  Stimulation of immune reconstitution by interleukin-7 after syngeneic bone marrow transplantation in mice. , 1996, Experimental hematology.

[44]  K. Weinberg,et al.  Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7. , 1996, Blood.

[45]  C. Thompson,et al.  Growth factors can enhance lymphocyte survival without committing the cell to undergo cell division. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[46]  G. Schuler,et al.  Interleukin 7 is produced by murine and human keratinocytes , 1993, The Journal of experimental medicine.

[47]  S. Nishikawa,et al.  Constitutive Expression of Interleukin‐7 mRNA and Production of IL‐7 by a Cloned Murine Thymic Stromal Cell Line , 1990, Journal of leukocyte biology.

[48]  D. Blaise,et al.  IMPACT OF T-CELL DEPLETION ON OUTCOME OF ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR STANDARD-RISK LEUKAEMIAS , 1987, The Lancet.